MED13L-related intellectual disability due to paternal germinal mosaicism
- PMID: 34654706
- PMCID: PMC8744498
- DOI: 10.1101/mcs.a006124
MED13L-related intellectual disability due to paternal germinal mosaicism
Abstract
The MED13L-related intellectual disability or MRFACD syndrome (Mental retardation and distinctive facial features with or without cardiac defects; MIM # 616789) is one of the most common forms of syndromic intellectual disability with about a hundred cases reported so far. Affected individuals share overlapping features comprising intellectual disability, hypotonia, motor delay, remarkable speech delay, and a recognizable facial gestalt. De novo disruption of the MED13L gene by deletions, duplications, or sequence variants has been identified as deleterious. Siblings affected by intragenic deletion transmitted from a mosaic parent have been reported once in the literature. We now present the first case of paternal germinal mosaicism for a missense MED13L variant causing MRFACD syndrome in one of the father's children and being the likely cause of intellectual disability and facial dysmorphism in the other. As part of the Mediator complex, the MED proteins have an essential role in regulating transcription. Thirty-two subunits of the Mediator complex genes have been linked to congenital malformations that are now acknowledged as transcriptomopathies. The MRFACD syndrome has been suggested to represent a recognizable phenotype.
Keywords: abnormality of the maxilla; delayed gross motor development; intellectual disability, moderate; secundum atrial septal defect.
© 2022 Bessenyei et al.; Published by Cold Spring Harbor Laboratory Press.
Figures
Similar articles
-
MED13L-related intellectual disability: involvement of missense variants and delineation of the phenotype.Neurogenetics. 2018 May;19(2):93-103. doi: 10.1007/s10048-018-0541-0. Epub 2018 Mar 6. Neurogenetics. 2018. PMID: 29511999
-
Report of a de novo c.2605C > T (p.Pro869Ser) change in the MED13L gene and review of the literature for MED13L-related intellectual disability.Ital J Pediatr. 2020 Jul 9;46(1):95. doi: 10.1186/s13052-020-00847-y. Ital J Pediatr. 2020. PMID: 32646507 Free PMC article. Review.
-
Genotype-phenotype evaluation of MED13L defects in the light of a novel truncating and a recurrent missense mutation.Eur J Med Genet. 2017 Sep;60(9):451-464. doi: 10.1016/j.ejmg.2017.06.004. Epub 2017 Jun 21. Eur J Med Genet. 2017. PMID: 28645799
-
Is MED13L-related intellectual disability a recognizable syndrome?Eur J Med Genet. 2019 Feb;62(2):129-136. doi: 10.1016/j.ejmg.2018.06.014. Epub 2018 Jun 27. Eur J Med Genet. 2019. PMID: 29959045
-
Two novel pathogenic variants in MED13L: one familial and one isolated case.J Intellect Disabil Res. 2021 Dec;65(12):1049-1057. doi: 10.1111/jir.12891. Epub 2021 Oct 28. J Intellect Disabil Res. 2021. PMID: 34713510 Review.
Cited by
-
MED13L-related disorder characterized by severe motor speech impairment.Res Sq [Preprint]. 2024 Aug 28:rs.3.rs-4790993. doi: 10.21203/rs.3.rs-4790993/v1. Res Sq. 2024. PMID: 39257968 Free PMC article. Preprint.
-
MED13L pathogenic missense variants impair protein stability and interaction, underlying diverse clinical outcomes.HGG Adv. 2025 Jul 10;6(3):100467. doi: 10.1016/j.xhgg.2025.100467. Epub 2025 Jun 11. HGG Adv. 2025. PMID: 40500968 Free PMC article.
-
Contribution of families using the GenIDA database to the description of MED13L syndrome and literature review.J Neurodev Disord. 2025 May 19;17(1):28. doi: 10.1186/s11689-025-09618-4. J Neurodev Disord. 2025. PMID: 40389839 Free PMC article. Review.
-
Quitting Your Day Job in Response to Stress: Cell Survival and Cell Death Require Secondary Cytoplasmic Roles of Cyclin C and Med13.Cells. 2025 Apr 25;14(9):636. doi: 10.3390/cells14090636. Cells. 2025. PMID: 40358161 Free PMC article. Review.
-
The MED13L Foundation strategic research plan: a roadmap to the future.Ther Adv Rare Dis. 2024 Nov 28;5:26330040241290252. doi: 10.1177/26330040241290252. eCollection 2024 Jan-Dec. Ther Adv Rare Dis. 2024. PMID: 39619418 Free PMC article.
References
-
- Asadollahi R, Oneda B, Sheth F, Azzarello-Burri S, Baldinger R, Joset P, Latal B, Knirsch W, Desai S, Baumer A, et al. 2013. Dosage changes of MED13L further delineate its role in congenital heart defects and intellectual disability. Eur J Hum Genet 21: 1100–1104. 10.1038/ejhg.2013.17 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials